BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14685063)

  • 1. Response to Soriano et al., 'Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?'.
    Matthews G; Dore G
    AIDS; 2003 Dec; 17(18):2675-6. PubMed ID: 14685063
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?
    Soriano V; Martín-Carbonero L; García-Samaniego J
    AIDS; 2003 Mar; 17(5):751-3. PubMed ID: 12646800
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic hepatitis C. Treatment of special groups].
    Civeira MP
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():68-70. PubMed ID: 11968348
    [No Abstract]   [Full Text] [Related]  

  • 4. Review article: predicting response in hepatitis C virus therapy.
    Mihm U; Herrmann E; Sarrazin C; Zeuzem S
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis C virus-related cirrhosis: is antiviral treatment mandatory?].
    Castera L; Roulot D; Trinchet JC; Beaugrand M
    Gastroenterol Clin Biol; 2001 May; 25(5):509-13. PubMed ID: 11521104
    [No Abstract]   [Full Text] [Related]  

  • 7. Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapy.
    Pineda JA; Macías J
    J Antimicrob Chemother; 2005 Apr; 55(4):417-9. PubMed ID: 15731202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When to treat and the benefits of treating hepatitis C in patients with haemophilia.
    Patel H; Heathcote EJ
    Haemophilia; 2009 Jan; 15(1):20-32. PubMed ID: 18976253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confronting chronic hepatitis B virus infection in HIV: new diagnostic tools and more weapons.
    Soriano V; Sheldon J; Ramos B; Núñez M
    AIDS; 2006 Feb; 20(3):451-3. PubMed ID: 16439880
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis viruses and human immunodeficiency virus co-infection: pathogenesis and treatment.
    Vallet-Pichard A; Pol S
    J Hepatol; 2004 Jul; 41(1):156-66. PubMed ID: 15246224
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of cirrhosis due to chronic hepatitis C.
    Everson GT
    J Hepatol; 2005; 42 Suppl(1):S65-74. PubMed ID: 15777574
    [No Abstract]   [Full Text] [Related]  

  • 12. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
    Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
    J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hepatitis C in the human immunodeficiency virus-infected patient: management strategies.
    Bhattacharya D; Imperial JC; Keeffe EB
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):288-92. PubMed ID: 16527689
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C virus antiviral therapy in patients with cirrhosis.
    Arenas JI; Vargas HE
    Gastroenterol Clin North Am; 2004 Sep; 33(3):549-62, ix. PubMed ID: 15324943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic interventions for HIV infection and chronic viral hepatitis.
    Cooper CL
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S69-72. PubMed ID: 16265617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of chronic hepatitis C].
    Rókusz L
    Orv Hetil; 2004 Aug; 145(32):1649-53. PubMed ID: 15384863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and therapy of chronic hepatitis C virus infection in HIV-infected individuals.
    Mauss S
    J HIV Ther; 2007 Mar; 12(1):11-7. PubMed ID: 17589391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of chronic hepatitis C and/or D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virus.
    Lacombe K; Boyd A; Desvarieux M; Serfaty L; Bonnord P; Gozlan J; Molina JM; Miailhes P; Lascoux-Combe C; Gault E; Girard PM
    AIDS; 2007 Nov; 21(18):2546-9. PubMed ID: 18025897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribavirin in the treatment of hepatitis C.
    Abonyi ME; Lakatos PL
    Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.